The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era

Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but ar...

Full description

Bibliographic Details
Published in:Canadian Journal of Gastroenterology and Hepatology
Main Authors: Sonya A MacParland, Marc Bilodeau, Jason Grebely, Julie Bruneau, Curtis Cooper, Marina Klein, Selena M Sagan, Norma Choucha, Louise Balfour, Frank Bialystok, Mel Krajden, Jennifer Raven, Eve Roberts, Rodney Russell, Michael Houghton, D Lorne Tyrrell, Jordan J Feld
Format: Article in Journal/Newspaper
Language:English
Published: Hindawi Limited 2014
Subjects:
Online Access:https://doi.org/10.1155/2014/704919
https://doaj.org/article/2476bb3e96734802921ca6a8e3bc7b10
id ftdoajarticles:oai:doaj.org/article:2476bb3e96734802921ca6a8e3bc7b10
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:2476bb3e96734802921ca6a8e3bc7b10 2023-05-15T16:16:43+02:00 The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era Sonya A MacParland Marc Bilodeau Jason Grebely Julie Bruneau Curtis Cooper Marina Klein Selena M Sagan Norma Choucha Louise Balfour Frank Bialystok Mel Krajden Jennifer Raven Eve Roberts Rodney Russell Michael Houghton D Lorne Tyrrell Jordan J Feld 2014-01-01T00:00:00Z https://doi.org/10.1155/2014/704919 https://doaj.org/article/2476bb3e96734802921ca6a8e3bc7b10 EN eng Hindawi Limited http://dx.doi.org/10.1155/2014/704919 https://doaj.org/toc/2291-2789 https://doaj.org/toc/2291-2797 2291-2789 2291-2797 doi:10.1155/2014/704919 https://doaj.org/article/2476bb3e96734802921ca6a8e3bc7b10 Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 9, Pp 481-487 (2014) Diseases of the digestive system. Gastroenterology RC799-869 article 2014 ftdoajarticles https://doi.org/10.1155/2014/704919 2022-12-30T22:21:28Z Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but are poorly tolerated. By 2014/2015, short-course, well-tolerated treatments with cure rates >95% will be available. However, treatment uptake is poor due to structural, financial, geographical, cultural and social barriers. As such, ‘Barriers to access to HCV care in Canada’ is a crucial topic that must be addressed to decrease HCV disease burden and potentially eliminate HCV in Canada. Understanding how to better care for HCV-infected individuals requires integration across multiple disciplines including researchers, clinical services and policy makers to address the major populations affected by HCV including people who inject drugs, baby boomers, immigrants and Aboriginal and/or First Nations people. In 2012, the National CIHR Research Training Program in Hepatitis C organized the 1st Canadian Symposium on Hepatitis C Virus (CSHCV) in Montreal, Quebec. The 2nd CSHCV was held in 2013 in Victoria, British Columbia. Both symposia were highly successful, attracting leading international faculty with excellent attendance leading to dialogue and knowledge translation among attendees of diverse backgrounds. The current article summarizes the 3rd CSHCV, held February 2014, in Toronto, Ontario. Article in Journal/Newspaper First Nations Directory of Open Access Journals: DOAJ Articles British Columbia ENVELOPE(-125.003,-125.003,54.000,54.000) Canada Canadian Journal of Gastroenterology and Hepatology 28 9 481 487
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle Diseases of the digestive system. Gastroenterology
RC799-869
Sonya A MacParland
Marc Bilodeau
Jason Grebely
Julie Bruneau
Curtis Cooper
Marina Klein
Selena M Sagan
Norma Choucha
Louise Balfour
Frank Bialystok
Mel Krajden
Jennifer Raven
Eve Roberts
Rodney Russell
Michael Houghton
D Lorne Tyrrell
Jordan J Feld
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
topic_facet Diseases of the digestive system. Gastroenterology
RC799-869
description Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but are poorly tolerated. By 2014/2015, short-course, well-tolerated treatments with cure rates >95% will be available. However, treatment uptake is poor due to structural, financial, geographical, cultural and social barriers. As such, ‘Barriers to access to HCV care in Canada’ is a crucial topic that must be addressed to decrease HCV disease burden and potentially eliminate HCV in Canada. Understanding how to better care for HCV-infected individuals requires integration across multiple disciplines including researchers, clinical services and policy makers to address the major populations affected by HCV including people who inject drugs, baby boomers, immigrants and Aboriginal and/or First Nations people. In 2012, the National CIHR Research Training Program in Hepatitis C organized the 1st Canadian Symposium on Hepatitis C Virus (CSHCV) in Montreal, Quebec. The 2nd CSHCV was held in 2013 in Victoria, British Columbia. Both symposia were highly successful, attracting leading international faculty with excellent attendance leading to dialogue and knowledge translation among attendees of diverse backgrounds. The current article summarizes the 3rd CSHCV, held February 2014, in Toronto, Ontario.
format Article in Journal/Newspaper
author Sonya A MacParland
Marc Bilodeau
Jason Grebely
Julie Bruneau
Curtis Cooper
Marina Klein
Selena M Sagan
Norma Choucha
Louise Balfour
Frank Bialystok
Mel Krajden
Jennifer Raven
Eve Roberts
Rodney Russell
Michael Houghton
D Lorne Tyrrell
Jordan J Feld
author_facet Sonya A MacParland
Marc Bilodeau
Jason Grebely
Julie Bruneau
Curtis Cooper
Marina Klein
Selena M Sagan
Norma Choucha
Louise Balfour
Frank Bialystok
Mel Krajden
Jennifer Raven
Eve Roberts
Rodney Russell
Michael Houghton
D Lorne Tyrrell
Jordan J Feld
author_sort Sonya A MacParland
title The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_short The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_full The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_fullStr The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_full_unstemmed The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_sort 3rd canadian symposium on hepatitis c virus: expanding care in the interferon-free era
publisher Hindawi Limited
publishDate 2014
url https://doi.org/10.1155/2014/704919
https://doaj.org/article/2476bb3e96734802921ca6a8e3bc7b10
long_lat ENVELOPE(-125.003,-125.003,54.000,54.000)
geographic British Columbia
Canada
geographic_facet British Columbia
Canada
genre First Nations
genre_facet First Nations
op_source Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 9, Pp 481-487 (2014)
op_relation http://dx.doi.org/10.1155/2014/704919
https://doaj.org/toc/2291-2789
https://doaj.org/toc/2291-2797
2291-2789
2291-2797
doi:10.1155/2014/704919
https://doaj.org/article/2476bb3e96734802921ca6a8e3bc7b10
op_doi https://doi.org/10.1155/2014/704919
container_title Canadian Journal of Gastroenterology and Hepatology
container_volume 28
container_issue 9
container_start_page 481
op_container_end_page 487
_version_ 1766002575551758336